Reports On Company: Alembic Pharma
| Alembic Pharmaceuticals Research Report By IIFL | |
| Company: | Alembic Pharma |
| Brokerage: | IIFL |
| Date of report: | January 6, 2021 |
| Type of Report: | Initiating Coverage |
| Recommendation: | Buy |
| Upside Potential: | 20% |
| Summary: | Strong all-round earnings |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | |